Skip to main content
Diseases
Companies
News
Policy
About
Resources
Build with
KISHO
Sign In
Sign Up
Open menu
Kisho
Glycostem Therapeutics B.V. — Rare Disease Pipeline | Kisho | Kisho
Glycostem Therapeutics B.V.
Other
1
Orphan Designations
0
FDA Approvals
1
Rare Diseases
0
News Articles
Pipeline
Designations
News
Diseases
Disease
Drug(s)
Designation
Approved
plasma cell myeloma
Allogeneic ex vivo-generated natural killer cells from CD34+ umbilical cord blood progenitor cells
Orphan Designation
-
← Back to Companies
